{
    "clinical_study": {
        "@rank": "75456", 
        "arm_group": [
            {
                "arm_group_label": "10mg Methotrexate (MTX) Group", 
                "arm_group_type": "Experimental", 
                "description": "Treatment Arm A - SC injection with Vibex device, Treatment Arm B - SC injection without device and Treatment Arm C - IM injection"
            }, 
            {
                "arm_group_label": "15mg Methotrexate (MTX) Group", 
                "arm_group_type": "Experimental", 
                "description": "Treatment Arm A - SC injection with Vibex device, Treatment Arm B - SC injection without device and Treatment Arm C - IM injection"
            }, 
            {
                "arm_group_label": "20mg Methotrexate (MTX) Group", 
                "arm_group_type": "Experimental", 
                "description": "Treatment Arm A - SC injection with Vibex device, Treatment Arm B - SC injection without device and Treatment Arm C - IM injection"
            }, 
            {
                "arm_group_label": "25mg Methotrexate (MTX) Group", 
                "arm_group_type": "Experimental", 
                "description": "Treatment Arm A - SC injection with Vibex device, Treatment Arm B - SC injection without device and Treatment Arm C - IM injection"
            }
        ], 
        "brief_summary": {
            "textblock": "Pharmacokinetics (PK) study"
        }, 
        "brief_title": "Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "[Administered via randomized sequence and crossover of Treatment Arm A, Treatment Arm B and Treatment Arm C]", 
                            "title": "10mg MTX Group"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "[Administered via randomized sequence and crossover of Treatment Arm A, Treatment Arm B and Treatment Arm C]", 
                            "title": "15mg MTX Group"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "[Administered via randomized sequence and crossover of Treatment Arm A, Treatment Arm B and Treatment Arm C]", 
                            "title": "20mg MTX Group"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "[Administered via randomized sequence and crossover of Treatment Arm A, Treatment Arm B and Treatment Arm C]", 
                            "title": "25mg MTX Group"
                        }, 
                        {
                            "@group_id": "B5", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "36"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "27"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "9"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "10.97", 
                                                "@value": "61.2"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "7.26", 
                                                "@value": "63.4"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "6.18", 
                                                "@value": "60.8"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@spread": "6.80", 
                                                "@value": "63.0"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@spread": "7.76", 
                                                "@value": "62.1"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "5"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "25"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "11"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "9"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "36"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "38 subjects were randomized to a treatment sequence. Two subjects discontinued prior to receiving the first study drug dose. Safety Population = 36 subjects who received study drug and completed all study visits. All 36 subjects were included in Pharmacokinetic Population. No discontinuations after first study drug dose."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "92.33", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "100.31", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The bioequivalence of Methotrexate following Treatment A - SC injection with the Vibex MTX device and Treatment B - SC injection without the device was established if the 90% CI for the geometric LS Mean ratios of AUC(0-inf)/Dose were within the range of 80% to 125%.", 
                                    "param_type": "Test / Reference Ratio", 
                                    "param_value": "96.24"
                                }, 
                                {
                                    "ci_lower_limit": "97.17", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "105.56", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The bioequivalence of Methotrexate following Treatment A-SC injection with the Vibex MTX device and Treatment C-IM injection was established if the 90% CI for the geometric LS Mean ratios of AUC(0-inf)/Dose were within the range of 80% to 125%.", 
                                    "param_type": "Test / Reference Ratio", 
                                    "param_value": "101.28"
                                }
                            ]
                        }, 
                        "description": "Dose-normalized area under the curve from time zero to infinity (AUC[0-inf]/Dose) for each treatment", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Subcutaneous (SC) injection with the Vibex MTX device", 
                                    "title": "Treatment Arm A"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "SC injection of MTX without the device", 
                                    "title": "Treatment Arm B"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Intramuscular (IM) injection of MTX", 
                                    "title": "Treatment Arm C"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "36"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "36"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "36"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "55.65", 
                                                        "@spread": "42.300", 
                                                        "@upper_limit": "213.94", 
                                                        "@value": "118.14"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "80", 
                                                        "@spread": "40.648", 
                                                        "@upper_limit": "125", 
                                                        "@value": "122.63"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "80", 
                                                        "@spread": "41.394", 
                                                        "@upper_limit": "125", 
                                                        "@value": "116.71"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Dose-normalized area under the curve from time zero to infinity (AUC[0-inf]/Dose) for each treatment", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Bioequivalence Based Upon Dose-Normalized AUC[0-Inf] for MTX", 
                                    "units": "ng*hr/mL/mg"
                                }
                            ]
                        }, 
                        "population": "The Population was defined as all randomized subjects who received at least 1 dose of study drug  and who had at least 1 valid post-dose plasma concentration value.", 
                        "safety_issue": "No", 
                        "time_frame": "24 Hour period", 
                        "title": "Bioequivalence Based Upon Dose-Normalized AUC[0-Inf] for MTX", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "92.32", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "100.28", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The bioequivalence of Methotrexate following Treatment A-SC injection with the Vibex MTX device and Treatment B-SC injection was established if the 90% CI for the geometric LS Mean ratios of AUC(0-24)/Dose were within the range of 80% to 125%.", 
                                    "param_type": "Test / Reference Ratio", 
                                    "param_value": "96.22"
                                }, 
                                {
                                    "ci_lower_limit": "97.06", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "105.40", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The bioequivalence of Methotrexate following Treatment A-SC injection with the Vibex MTX device and Treatment C-IM injection was established if the 90% CI for the geometric LS Mean ratios of AUC(0-24)/Dose were within the range of 80% to 125%.", 
                                    "param_type": "Test / Reference Ratio", 
                                    "param_value": "101.14"
                                }
                            ]
                        }, 
                        "description": "Dose-normalized area under the curve from time zero to 24 hours post-dose (AUC[0-24]/Dose) for each treatment", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Subcutaneous (SC) injection with the Vibex MTX device", 
                                    "title": "Treatment Arm A"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "SC injection of MTX without the device", 
                                    "title": "Treatment Arm B"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Intramuscular (IM) injection of MTX", 
                                    "title": "Treatment Arm C"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "36"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "36"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "36"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "40.963", 
                                                        "@value": "116.60"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "39.405", 
                                                        "@value": "121.08"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "40.648", 
                                                        "@value": "122.63"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Dose-normalized area under the curve from time zero to 24 hours post-dose (AUC[0-24]/Dose) for each treatment", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Bioequivalence Based Upon Dose-Normalized AUC[0-24] for MTX", 
                                    "units": "ng*hr/mL/mg"
                                }
                            ]
                        }, 
                        "population": "Dose-normalized MTX PK parameter AUC(0-24)/Dose used for comparison", 
                        "safety_issue": "No", 
                        "time_frame": "24 Hour period", 
                        "title": "Bioequivalence Based Upon Dose-Normalized AUC[0-24] for MTX", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "87.93", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "106.47", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The bioequivalence of Methotrexate following Treatment A-SC injection with the Vibex MTX device and Treatment B-SC injection without the device was established if the 90% CI for the geometric LS Mean ratios of Cmax/Dose were within the range of 80% to 125%.", 
                                    "param_type": "Test / Reference Ratio", 
                                    "param_value": "96.76"
                                }, 
                                {
                                    "ci_lower_limit": "81.61", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "90", 
                                    "ci_upper_limit": "98.78", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "non_inferiority": "Yes", 
                                    "non_inferiority_desc": "The bioequivalence of Methotrexate following Treatment A-SC injection with the Vibex MTX device and Treatment C-IM injection was established if the 90% CI for the geometric LS Mean ratios of Cmax/Dose were within the range of 80% to 125%.", 
                                    "param_type": "Test / Reference Ratio", 
                                    "param_value": "89.79"
                                }
                            ]
                        }, 
                        "description": "Dose-normalized maximum observed concentration for each treatment", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Subcutaneous (SC) injection with the Vibex MTX device", 
                                    "title": "Treatment Arm A"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "SC injection of MTX without the device", 
                                    "title": "Treatment Arm B"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Intramuscular (IM) injection of MTX", 
                                    "title": "Treatment Arm C"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "36"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "36"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "36"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "8.310", 
                                                        "@value": "21.43"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "10.263", 
                                                        "@value": "22.38"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "7.188", 
                                                        "@value": "23.37"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Dose-normalized maximum observed concentration for each treatment", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Bioequivalence Based Upon Dose-Normalized Cmax for MTX", 
                                    "units": "ng/mL/mg"
                                }
                            ]
                        }, 
                        "population": "The Population was defined as all randomized subjects who received at least 1 dose of study drug  and who had at least 1 valid post-dose plasma concentration value.", 
                        "safety_issue": "No", 
                        "time_frame": "24 Hour period", 
                        "title": "Bioequivalence Based Upon Dose-Normalized Cmax for MTX", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "[administered via randomized sequence and crossover of Treatment Arm A -SC injection with Vibex MTX device, Treatment Arm B -SC injection without device and Treatment Arm C -IM Injection]", 
                            "title": "10mg MTX Group"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "[administered via randomized sequence and crossover of Treatment Arm A -SC injection with Vibex MTX device, Treatment Arm B -SC injection without device and Treatment Arm C -IM Injection]", 
                            "title": "15mg MTX Group"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "[administered via randomized sequence and crossover of Treatment Arm A -SC injection with Vibex MTX device, Treatment Arm B -SC injection without device and Treatment Arm C -IM Injection]", 
                            "title": "20mg MTX Group"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "[administered via randomized sequence and crossover of Treatment Arm A -SC injection with Vibex MTX device, Treatment Arm B -SC injection without device and Treatment Arm C -IM Injection]", 
                            "title": "25mg MTX Group"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "9", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "#text": "10 patients randomized, one patient discontinued before first study drug dose", 
                                                "@count": "9", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "#text": "10 patients randomized, one patient discontinued before first study drug dose", 
                                                "@count": "9", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "9", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "The order of Methotrexate (MTX) treatment arms (A-SC injection with Vibex-MTX device, B-SC injection without device and C-IM Injection) were randomly assigned and dosing was separated by interval of atleast 7 days to allow for washout before the next treatment was administered.", 
                "recruitment_details": "Subjects were screened and enrolled at 2 sites in the US. Approximately equal number of subjects on 10 mg, 15 mg, 20 mg and 25 mg doses were recruited. The dose group was determined by the Investigator based on subject's current therapeutic regimen of MTX and disease status. The patient's dose was the same for the entire study."
            }, 
            "point_of_contact": {
                "email": "jjaffe@antarespharma.com", 
                "name_or_title": "Jonathan Jaffe, MD; Vice President Clinical Development", 
                "organization": "Antares Pharma", 
                "phone": "1-609-359-3020 ext 324"
            }, 
            "reported_events": {
                "desc": "Adverse events were classified by treatment at onset. Any adverse event that occurred on Day 1 (after check-in) for a given treatment period was assigned to the treatment for that period.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "[Administered via randomized sequence and crossover of Treatment A, Treatment B and Treatment C]", 
                            "title": "10mg MTX"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "[Administered via randomized sequence and crossover of Treatment A, Treatment B and Treatment C]", 
                            "title": "15mg MTX"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "[Administered via randomized sequence and crossover of Treatment A, Treatment B and Treatment C]", 
                            "title": "20mg MTX"
                        }, 
                        {
                            "@group_id": "E4", 
                            "description": "[Administered via randomized sequence and crossover of Treatment A, Treatment B and Treatment C]", 
                            "title": "25mg MTX"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }
                                        ], 
                                        "description": "AE Occurred During Treatment B", 
                                        "sub_title": "Injection site erythema"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }
                                        ], 
                                        "description": "AE Occurred During Treatment A", 
                                        "sub_title": "Nasopharyngitis"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }
                                        ], 
                                        "description": "AE Occurred During Treatment A", 
                                        "sub_title": "Maculopapular rash"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E3", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "9"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E4", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "9"
                                            }
                                        ], 
                                        "description": "AE Occurred During Treatment B", 
                                        "sub_title": "Hypertension"
                                    }
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 13.1", 
                    "frequency_threshold": "2.8"
                }, 
                "time_frame": "The Safety Population was defined as all randomized subjects who received at least 1 dose of study drug. The Safety Population included 36 subjects."
            }
        }, 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "detailed_description": {
            "textblock": "To compare the pharmacokinetic (PK) profiles of methotrexate (MTX) following a subcutaneous\n      (SC) injection of MTX using the Vibex device to that obtained after an SC injection of MTX\n      without using the device and to that obtained after an intramuscular (IM) injection of MTX\n      in adult subjects with rheumatoid arthritis (RA)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female >18 years of age with diagnosed Rheumatoid Arthritis(RA).\n\n        Exclusion Criteria:\n\n          -  Chronic or acute renal disease\n\n          -  Any other clinically significant disease or disorder which, in the opinion of the\n             investigator, might put the subject at risk"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "38", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "firstreceived_results_date": "January 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737944", 
            "org_study_id": "MTX-10-001"
        }, 
        "intervention": {
            "arm_group_label": [
                "10mg Methotrexate (MTX) Group", 
                "15mg Methotrexate (MTX) Group", 
                "20mg Methotrexate (MTX) Group", 
                "25mg Methotrexate (MTX) Group"
            ], 
            "description": "Vibex MTX Device", 
            "intervention_name": "Methotrexate (MTX)", 
            "intervention_type": "Drug", 
            "other_name": "Device with MTX"
        }, 
        "intervention_browse": {
            "mesh_term": "Methotrexate"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "methotrexate injection, subcutaneous, autoinjector", 
        "lastchanged_date": "January 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Duncansville", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "16635"
                }, 
                "name": "Altoona Center for Clinical Research"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Exposure, Safety and Local Tolerance Study Comparing 3 Routes of Methotrexate (MTX) Administration: Vibex-MTX Device, Subcutaneous (SC)and Intramuscular (IM) in Adult Subjects With Rheumatoid Arthritis", 
        "overall_official": {
            "affiliation": "Altoona Center for Clinical Research", 
            "last_name": "Alan J Kivitz, MD;CPI", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Dose-normalized area under the curve from time zero to infinity (AUC[0-inf]/Dose) for each treatment", 
                "measure": "Bioequivalence Based Upon Dose-Normalized AUC[0-Inf] for MTX", 
                "safety_issue": "No", 
                "time_frame": "24 Hour period"
            }, 
            {
                "description": "Dose-normalized area under the curve from time zero to 24 hours post-dose (AUC[0-24]/Dose) for each treatment", 
                "measure": "Bioequivalence Based Upon Dose-Normalized AUC[0-24] for MTX", 
                "safety_issue": "No", 
                "time_frame": "24 Hour period"
            }, 
            {
                "description": "Dose-normalized maximum observed concentration for each treatment", 
                "measure": "Bioequivalence Based Upon Dose-Normalized Cmax for MTX", 
                "safety_issue": "No", 
                "time_frame": "24 Hour period"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737944"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Antares Pharma Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Antares Pharma Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}